Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Similar documents
Starpharma Holdings Limited (SPL) - Medical Equipment - Deals and Alliances Profile

ConvaTec Group Plc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acadia Pharmaceuticals Inc. (ACAD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bionure Farma SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Natera, Inc. (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Nektar Therapeutics (NKTR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Glenmark Pharmaceuticals Inc., USA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Karo Pharma AB (KARO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bessemer Venture Partners - Pharmaceuticals & Healthcare - Deals and Alliances Profile

DNA2.0 Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Median Kliniken GmbH & Co. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Collegium Pharmaceutical Inc (COLL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Faes Farma SA (FAE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Vanderbilt University - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioton SA (BIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mesa Laboratories, Inc. (MLAB) - Medical Equipment - Deals and Alliances Profile

Becton, Dickinson and Company (BDX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Mindray Medical International Limited (MR) - Medical Equipment - Deals and Alliances Profile

DaVita HealthCare Partners Inc. (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Paramount Mining Corporation Limited (PCP) - Metals and Mining - Deals and Alliances Profile

The Walt Disney Company - Strategy, SWOT and Corporate Finance Report

McCain Foods Limited, Inc. - Strategic SWOT Analysis Review

Vorwerk and Co. KG - Strategy, SWOT and Corporate Finance Report

Gap, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Kohler Co. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Phone: +44 (0) or BioPortfolio Limited

Maruti Suzuki India Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Surgical Sutures Market By Product Type [Automated Suturing Devices (Disposable Automated Suturing Devices, And Re-Usable Automated Suturing

Compression Therapy - Medical Devices Pipeline Assessment, 2017

Critical Limb Ischemia - Pipeline Review, H1 2017

Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

Generics Series: Authorized Generics Analysis Stemming the Generics Tide

United States Sterilization Equipment Market Outlook to 2021

Data-Driven Evaluation: The Key to Developing Successful Pharma Partnerships

Military Robotics - Emerging Trends and Future Outlook. Reference code: DF4580PR Published: July 2015 Single user price: US$1950

Venture Capital Report

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

Digital Health Funding and M&A

Global Paper Stationery Market Research Report 2016

Global Absolute Pressure Transmitters Market Research Report 2016

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

April By Type of Approach- Transfemoral and Transapical. By Region- North America, Europe, APAC and RoW

Annual Press Conference Financial year 2017

Venture Capital Report

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

Indoor Positioning and Navigation System Market Research Report- Forecast 2023

Intellectual property governance and strategic value creation:

Dealdoc. Acquisition agreement for Gambro. Baxter International Gambro. Dec , Wildwood Ventures Ltd. All rights reserved.

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE

HBM Healthcare Investments Ltd Access to a Global and Diversified Private Equity Healthcare Portfolio

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

Mara H. Rogers, Partner Norton Rose Fulbright

Global DAW Software Market Research Report 2016

Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast,

2013 Global venture capital confidence survey results. How confident are investors?

Purvi B. Maniar Member of the Firm

Local Production of Pharmaceuticals and Related Technology Transfer UNCTAD/CD-TFT 1. Background

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)

Nasir, Dao PKM Abdul Partner PwC Legal (Vietnam) Co., Ltd

Pharma - Biotech Collaborations: Optimizing Success, Minimizing Risk and Maintaining Alignment

Venture Capital Report

Licensing League Tables 3Q14

Venture Capital Report

Venture Capital Report

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

Cherry AB. Investing in a broad gaming portfolio. CEO Anders Holmgren GP Bullhound 6 December 2017

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Neurostimulation Devices Market - An Overview 3.

Life Sciences Outlook. New York City 2016

Kandace P. Watson Partner

World Offshore Wind Market Forecast Prospects, Technologies, World Markets

Global and China Industrial Robot Industry Report, Sep. 2013

Robert A. Greising Partner

I Overview. II Hallmarks of Turnpoint Group. III Corporate Financial Services. IV Assignments. V Clients. VI Market Segments

EXAMINATION NUMBER ONLY.

Commercialization Strategies that Work

China Ophthalmic Hospital Industry Report, May 2013

CeQur establishes Wales subsidiary

Robert A. Greising Partner

VentureSource Europe -- 3Q 2014

Q&A with Samira Salman

Master Class : Excellence in Private Equity & Deal Structuring

Global and China Industrial Robot Speed Reducer Industry Report, Jun. 2014

Advised Mubadala Development Company PJSC in connection with the sale of interests in a ports operating company.

New York Bar admission (or eligibility to obtain admission promptly) is required.

Chartwell Introduction and AEC Capabilities

State of Licensing 2011 Update

2 nd Quarter Earnings Conference Call

Reinventing Invention: Advancing Collaboration for Sustainable Bioscience R&D

IVC-MEITAR HIGH-TECH EXITS H1/ 2015 REPORT. IVC-Meitar 2014 Exits Report Prepared by IVC Research Center Ltd.

Top 50 Emerging Technologies & Growth Opportunities

Global Sequins Apparels Market Research Report 2016

EXECUTIVE SUMMARY. Investment Opportunity. Paradox Financial Solutions Inc.

Patenting Strategies. The First Steps. Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1

Corporate Profile. Sep 2009

Cannabis Practice Group

Transcription:

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Starpharma Holdings Limited (Starpharma) develops dendrimer products for pharmaceutical, life science and other applications. It has three development programs namely, VivaGel portfolio, drug delivery and agrochemicals. The company also markets its products through license arrangements with partners such as Siemens Healthcare and Merck KgaA, among others. Its flagship product VivaGel (under clinical development) is a gel-based formulation of a proprietary dendrimer for the treatment and prevention of bacterial vaginosis (BV) and also as a vaginal microbicide to prevent the transmission of sexually transmitted infections including HIV and genital herpes. Starpharma s research facilities are located in Melbourne, Australia. It is headquartered in Melbourne, Australia. Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of 3

the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH81790D Number of Pages : 34 Report Format : PDF Publisher Information : 4

5

Table Of Contents for Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5Starpharma Holdings Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8Starpharma Holdings Limited, Medical Devices Deals, 2010 to YTD 2016 9Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deal Details 11Partnerships 11Starpharma to Enter into Agreement with Chinese Company 11Starpharma Holdings Expands Research Agreement With Eli Lilly 12Starpharma Holdings Enters Into Research Collaboration With Eli Lilly 13Starpharma Enters Into An Agreement With Eli Lilly 14Licensing Agreements 15Aspen Pharma Enters into Licensing Agreement with Starpharma 15AstraZeneca Enters into Licensing Agreement with Starpharma 16Starpharma Terminates Licensing Agreement With Reckitt Benckiser For VivaGel 17Starpharma Holdings Enters Into Licensing Agreement With Ansell For VivaGel 18Starpharma Holdings Enters Into Licensing Agreement With Okamoto Industries 20Equity Offering 21Starpharma Raises USD1.4 Million in Share Purchase Plan 21Starpharma Raises USD23 Million in Private Placement of Shares 23Starpharma Raises USD16 Million in Private Placement of Shares 25Starpharma Holdings Completes Rights Offering Of Common Stock For US$3 Million 27Starpharma Holdings Completes Private Placement Of Shares For US$32.6 Million 29Starpharma Holdings Limited - Key Competitors 31Key Employees 32Locations And Subsidiaries 33Head Office 33Other Locations & Subsidiaries 33Appendix 34Methodology 34About GlobalData 34Contact Us 34Disclaimer 34 6

List Of Tables in Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Key Facts, 2015 1 Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Starpharma Holdings Limited, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Starpharma Holdings Limited, Deals By Therapy Area, 2010 to YTD 2016 8 Starpharma Holdings Limited, Medical Devices Deals, 2010 to YTD 2016 9 Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10 Starpharma to Enter into Agreement with Chinese Company 11 Starpharma Holdings Expands Research Agreement With Eli Lilly 12 Starpharma Holdings Enters Into Research Collaboration With Eli Lilly 13 Starpharma Enters Into An Agreement With Eli Lilly 14 Aspen Pharma Enters into Licensing Agreement with Starpharma 15 AstraZeneca Enters into Licensing Agreement with Starpharma 16 Starpharma Terminates Licensing Agreement With Reckitt Benckiser For VivaGel 17 Starpharma Holdings Enters Into Licensing Agreement With Ansell For VivaGel 18 Starpharma Holdings Enters Into Licensing Agreement With Okamoto Industries 20 Starpharma Raises USD1.4 Million in Share Purchase Plan 21 Starpharma Raises USD23 Million in Private Placement of Shares 23 Starpharma Raises USD16 Million in Private Placement of Shares 25 Starpharma Holdings Completes Rights Offering Of Common Stock For US$3 Million 27 Starpharma Holdings Completes Private Placement Of Shares For US$32.6 Million 29 Starpharma Holdings Limited, Key Competitors 31 Starpharma Holdings Limited, Key Employees 32 Starpharma Holdings Limited, Subsidiaries 33 7

List Of Figures, Charts and Diagrams in Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1 Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1 Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1 Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1 Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6 Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Starpharma Holdings Limited, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8 Starpharma Holdings Limited, Medical Devices Deals, 2010 to YTD 2016 9 8

How to Buy... Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 9